Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05938296 |
| Title | oHSV2-PD-L1/CD3-BsAb Administered Via Intramural Injection |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Binhui Biopharmaceutical Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Orlando Health Cancer Institute | RECRUITING | Orlando | Florida | 32806 | United States | Details |
| Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center | RECRUITING | Detroit | Michigan | 48201 | United States | Details |